| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 4,706 | 2,019 | 1,708 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 4,706 | 2,019 | 1,708 | | | Operating Expenses | | Research Development | 13,161 | 17,430 | 6,990 | | Selling General and Administrative | 5,890 | 10,531 | 2,137 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (14,345) | (25,942) | (7,418) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 319 | (1,053) | 207 | | Earnings Before Interest And Taxes | (14,026) | (26,995) | (7,211) | | Interest Expense |
-
| 1 | 11 | | Income Before Tax | (14,026) | (26,997) | (7,223) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (14,026) | (26,997) | (7,223) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (14,026) | (26,997) | (7,223) | | Preferred Stock And Other Adjustments | (1,182) | (1,266) | (215) | | | Net Income Applicable To Common Shares | ($15,208) | ($28,262) | ($7,438) |
|
0.31% Nasdaq 
0.05%
Income Statement
